中国实用内科杂志 ›› 2012, Vol. 32 ›› Issue (12): 932-934.
• 指南论坛 • 上一篇 下一篇
陈旻
出版日期:
发布日期:
CHEN Min
Online:
Published:
摘要:
原发性小血管炎是一组累及全身多系统特别是肾脏和肺脏的自身免疫性疾病,根据KDIGO指南,其治疗主要分为初始治疗和维持治疗,初始治疗是应用糖皮质激素联合细胞毒性药物(特别是环磷酰胺或利妥昔单抗),对于重症患者应采取必要的抢救措施,包括大剂量甲泼尼龙冲击和血浆置换治疗。维持缓解主要是长期应用免疫抑制剂治疗,特别是硫唑嘌呤或吗替麦考酚酯等。复发的患者可以根据其复发的程度适当增加糖皮质激素和(或)免疫抑制剂的剂量,甚至重新按照初始的诱导治疗方案进行治疗。
关键词: 小血管炎, 抗中性粒细胞胞浆抗体, 免疫抑制剂, 糖皮质激素
Abstract:
Primary small vessel vasculitis has been pathologically classified as a spectrum of autoimmune diseases involving the kidneys and lungs.Treatment of primary small vessel vasculitis,based on the KDIGO guideline,included initial and maintenance therapy.Initial treatment consisted mainly of corticosteroids and cytotoxic medications (esp.cyclophosphamide,rituximab) and may involve highdose methylprednisolone and plasma exchange therapy as an emergent surrogate in severe cases,while the maintenance therapy mostly included the immunosuppressants,typically,azathioprine and mycophenolate mofetil.The treatment could be initiated by increasing the doses of corticosteroids or immunosuppressants according to the severity of relapse and,if warranted,repeat the induction protocol for initial therapy.
Key words: vasculitis, anti-neutrophil cytoplasmic antibody, immunosuppressant, glucocorticoid
中图分类号:
R543
陈旻. KDIGO指南解读:血管炎肾损伤治疗[J]. 中国实用内科杂志, 2012, 32(12): 932-934.
CHEN Min. Treatment of vasculitisinduced renal Injury:interpretation of KDIGO guideline.[J]. , 2012, 32(12): 932-934.
0 / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: http://www.zgsyz.com/zgsynk/CN/
http://www.zgsyz.com/zgsynk/CN/Y2012/V32/I12/932